BillionToOne YC Application
BillionToOne went through Y Combinator in the Summer 2017 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Summer 2017
- Industry
- HealthcareDiagnostics
- Team size
- 300
- Status
- Public
- Launched
- 2016
Founders
Oguzhan AtayFounder
David TsaoFounder/CTO
What BillionToOne does
BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.
BillionToOne's YC application, reconstructed
Y Combinator application
BillionToOne, Summer 2017 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
BillionToOne
The genetic testing platform detecting and measuring disease.
We have built a DNA molecular counter that improves the resolution of cell-free DNA diagnostics by over a thousand times. Our main product, UNITY Screen, is a non-invasive prenatal test that uniquely assesses fetal risk for recessive conditions and chromosomal abnormalities from maternal blood. We are expanding this technology into liquid biopsy tests for cancer, aiming to transform how oncology care detects and monitors disease.
We currently live and work in Menlo Park, CA, and would keep the company based there after YC.
We are based in Menlo Park because it provides access to top scientific talent and proximity to leading healthcare and biotech partners, which is critical for developing and refining our complex diagnostics technology.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real BillionToOne YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from BillionToOne's public data (launch notes, founder backgrounds, product description). It shows how a company like BillionToOne would present itself to YC, not the text they submitted.
What YC batch was BillionToOne in?
BillionToOne was part of the Y Combinator Summer 2017 batch.
Who founded BillionToOne?
BillionToOne was founded by Oguzhan Atay, David Tsao.
What does BillionToOne do?
The genetic testing platform detecting and measuring disease.
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of BillionToOne's application, and every other YC batch, is in YC Insights.
More YC startups like BillionToOne
